| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 656238 | 68105 | GLUCOSAMINA CINFA 1500 mg POLVO PARA SOLUCION ORAL EFG | GLUCOSAMINA CINFA 1500 mg POLVO PARA SOLUCION ORAL EFG, 30 sobres | 1.500 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68105/68105_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68105/68105_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-10-25 | 1 | 1 | 1 | 2006-10-25 | 2006-10-25 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656748 | 29243 | CAOSINA 1.000 MG POLVO PARA SUSPENSIÓN ORAL. | CAOSINA 1.000 MG POLVO PARA SUSPENSIÓN ORAL. , 60 sobres | 2.500 mg (1.000 mg Ca) | 35 | 60 | 64 | 60 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/29243/29243_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/29243/29243_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1958-05-01 | 1 | 1 | 1 | 1958-05-01 | 2008-03-06 | 1 | 2011-09-09 | 652446, 820357 | View Edit Delete | |||||||||||
| 656254 | 65455 | XUMADOL 1 g GRANULADO EFERVESCENTE EFG | XUMADOL 1 g GRANULADO EFERVESCENTE EFG , 20 sobres | 1.000 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65455/65455_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65455/65455_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | ITALFARMACO S.A. | 2003-06-23 | 1 | 1 | 1 | 2015-05-11 | 2015-05-11 | 1 | 2012-10-09 | 850891 | View Edit Delete | |||||||||||
| 656255 | 65455 | XUMADOL 1 g GRANULADO EFERVESCENTE EFG | XUMADOL 1 g GRANULADO EFERVESCENTE EFG , 40 sobres | 1.000 mg | 35 | 40 | 64 | 40 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65455/65455_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65455/65455_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | ITALFARMACO S.A. | 2003-06-23 | 1 | 1 | 1 | 2015-05-11 | 2015-05-11 | 1 | 2012-10-09 | 819458 | View Edit Delete | |||||||||||
| 656798 | 59098 | PROFER 40 mg GRANULADO PARA SOLUCION ORAL | PROFER 40 mg GRANULADO PARA SOLUCION ORAL , 30 sobres | 40 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59098/59098_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59098/59098_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32379 | MEIJI PHARMA SPAIN S.A. | 1991-07-01 | 1 | 1 | 1 | 1991-07-01 | 2008-07-09 | 1 | 2012-01-02 | 830182 | View Edit Delete | |||||||||||
| 656284 | 68125 | MOVIPREP POLVO PARA SOLUCION ORAL | MOVIPREP POLVO PARA SOLUCION ORAL , 2 sobres de 112 g + 2 sobres de 11 g | N/A (más de 4 PA) | 35 | 1 | 17 | 2 sobres de 112 g + 2 sobres de 11 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68125/68125_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68125/68125_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30058 | NORGINE DE ESPANA S.L.U. | 2006-11-02 | 1 | 1 | 1 | 2006-11-02 | 2006-11-02 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 656755 | 64546 | CARTISORB 1500 mg POLVO PARA SOLUCION ORAL | CARTISORB 1500 mg POLVO PARA SOLUCION ORAL , 30 sobres | 1.500 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64546/64546_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64546/64546_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2002-02-04 | 1 | 1 | 1 | 2002-02-04 | 2008-03-14 | 1 | 2011-10-10 | 750307 | View Edit Delete | |||||||||||
| 655938 | 67988 | ACETILCISTEINA SANDOZ CARE 600 mg COMPRIMIDOS EFERVESCENTES | ACETILCISTEINA SANDOZ CARE 600 mg COMPRIMIDOS EFERVESCENTES , 20 comprimidos (sobres) | 600 mg | 35 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67988/67988_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67988/67988_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2006-09-22 | 1 | 1 | 1 | 2006-09-22 | 2006-09-22 | 1 | 2025-08-20 | View Edit Delete | ||||||||||||
| 658197 | 68301 | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO , 7 parches | 14 mg/24 h | 35 | 7 | 28 | 7 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68301/68301_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68301/68301_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71300 | VEMEDIA PHARMA HISPANIA S.A. | 2006-12-22 | 1 | 1 | 1 | 2006-12-22 | 2006-12-22 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 658198 | 68301 | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO , 14 parches | 14 mg/24 h | 35 | 14 | 28 | 14 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68301/68301_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68301/68301_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71300 | VEMEDIA PHARMA HISPANIA S.A. | 2006-12-22 | 1 | 1 | 1 | 2006-12-22 | 2006-12-22 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 658200 | 68301 | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO , 28 parches | 14 mg/24 h | 35 | 28 | 28 | 28 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68301/68301_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68301/68301_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71300 | VEMEDIA PHARMA HISPANIA S.A. | 2006-12-22 | 1 | 1 | 1 | 2006-12-22 | 2006-12-22 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 658204 | 68302 | NICOTINELL 7 MG/24 HORAS PARCHE TRANSDERMICOS | NICOTINELL 7 MG/24 HORAS PARCHE TRANSDERMICOS , 14 parches | 7 mg/24 h | 35 | 14 | 28 | 14 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68302/68302_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68302/68302_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71300 | VEMEDIA PHARMA HISPANIA S.A. | 2006-12-22 | 1 | 1 | 1 | 2006-12-22 | 2006-12-22 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 658207 | 68303 | NICOTINELL 21 MG/24 HORAS PARCHE TRANSDERMICO | NICOTINELL 21 MG/24 HORAS PARCHE TRANSDERMICO , 7 parches | 21 mg/24 h | 35 | 7 | 28 | 7 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68303/68303_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68303/68303_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71300 | VEMEDIA PHARMA HISPANIA S.A. | 2006-12-22 | 1 | 1 | 1 | 2006-12-22 | 2006-12-22 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 658208 | 68303 | NICOTINELL 21 MG/24 HORAS PARCHE TRANSDERMICO | NICOTINELL 21 MG/24 HORAS PARCHE TRANSDERMICO , 14 parches | 21 mg/24 h | 35 | 14 | 28 | 14 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68303/68303_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68303/68303_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71300 | VEMEDIA PHARMA HISPANIA S.A. | 2006-12-22 | 1 | 1 | 1 | 2006-12-22 | 2006-12-22 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 658210 | 68303 | NICOTINELL 21 MG/24 HORAS PARCHE TRANSDERMICO | NICOTINELL 21 MG/24 HORAS PARCHE TRANSDERMICO , 28 parches | 21 mg/24 h | 35 | 28 | 28 | 28 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68303/68303_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68303/68303_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71300 | VEMEDIA PHARMA HISPANIA S.A. | 2006-12-22 | 1 | 1 | 1 | 2006-12-22 | 2006-12-22 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 658266 | 66203 | XICIL 1500 MG POLVO PARA SOLUCIÓN ORAL EFG | XICIL 1500 MG POLVO PARA SOLUCIÓN ORAL EFG, 30 sobres | 1.500 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66203/66203_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66203/66203_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67965 | VEMEDIA PHARMA HISPANIA S.A. | 2004-07-01 | 1 | 1 | 1 | 2004-07-01 | 2007-01-17 | 1 | 2011-02-11 | 650782 | View Edit Delete | |||||||||||
| 656600 | 62670 | PENTASA 1g GRANULADO DE LIBERACION PROLONGADA | PENTASA 1g GRANULADO DE LIBERACION PROLONGADA , 50 sobres | 1.000 mg | 35 | 50 | 64 | 50 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62670/62670_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62670/62670_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 31840 | FERRING S.A.U. | 1999-08-01 | 1 | 1 | 1 | 1999-08-01 | 2007-07-11 | 0 | 2011-06-28 | 822197 | View Edit Delete | |||||||||||
| 656601 | 62670 | PENTASA 1g GRANULADO DE LIBERACION PROLONGADA | PENTASA 1g GRANULADO DE LIBERACION PROLONGADA , 100 sobres | 1.000 mg | 35 | 100 | 64 | 100 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62670/62670_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62670/62670_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 31840 | FERRING S.A.U. | 1999-08-01 | 1 | 1 | 1 | 1999-08-01 | 2007-07-11 | 0 | 2011-06-28 | 777615 | View Edit Delete | |||||||||||
| 655958 | 68002 | GLUCOSAMINA NORMON 1500 mg POLVO PARA SOLUCION ORAL EFG | GLUCOSAMINA NORMON 1500 mg POLVO PARA SOLUCION ORAL EFG, 20 sobres | 1.500 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68002/68002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68002/68002_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2006-08-23 | 1 | 1 | 1 | 2006-08-23 | 2006-08-23 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 655959 | 68002 | GLUCOSAMINA NORMON 1500 mg POLVO PARA SOLUCION ORAL EFG | GLUCOSAMINA NORMON 1500 mg POLVO PARA SOLUCION ORAL EFG, 30 sobres | 1.500 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68002/68002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68002/68002_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2006-08-23 | 1 | 1 | 1 | 2006-08-23 | 2006-08-23 | 1 | 2011-10-20 | View Edit Delete |
Page 131 of 1036, showing 20 records out of 20709 total, starting on record 2601, ending on 2620